Percentage of patients taking concomitant oral agents, by visit: N = 379.
| CLASS | PROPORTION OF PATIENTS | ||
|---|---|---|---|
| VISIT 1 | VISIT 2 | VISIT 3 | |
| Metformin | 63.5 | 56.7 | 52.8 |
| Thiazolidinediones | 10.5 | 10.0 | 7.9 |
| Sulfonylureas | 26.3 | 17.1 | 11.3 |
| Meglitinides | 5.0 | 2.9 | 2.6 |
| α-Glucosidase inhibitors | 1.6 | 0.5 | 0.8 |
| Orlistat | 0.8 | 1.0 | 0.8 |
| Combination formulations | 1.3 | 0.3 | 1.0 |